Mosaic ImmunoEngineering Inc.
Mosaic ImmunoEngineering Inc. (CPMV) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cpmv · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Mosaic ImmunoEngineering Inc. (CPMV) measures how much investors pay for each dollar of the company's trailing earnings. CPMV's current PE ratio of N/A is calculated by dividing its stock price of $0.69 by its TTM earnings per share of -$0.09.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2005 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%4.8x
MedianQ3 · 75%52.6x
Max
At N/A, CPMV's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Mosaic ImmunoEngineering Inc.You CPMV | $5M | N/A | — | -$0.09 |
 BetterLife Pharma Inc. BETRF | $7M | N/A | — | -$0.01 |
 Bioxytran, Inc. BIXT | $3M | N/A | — | -$0.02 |
 Burzynski Research Institute, Inc. BZYR | $1M | N/A | — | -$0.01 |
 Curative Biotechnology, Inc. CUBT | $11M | N/A | — | -$0.00 |
 Glow Lifetech Corp. GLWLF | $6M | N/A | — | -$0.00 |
 NanoSphere Health Sciences Inc. NSHSF | $0M | N/A | — | -$0.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.10 | — | |
2024-12-31 FY2024 | — | $-0.13 | — | |
2022-12-31 FY2022 | — | $-0.33 | — | |
2021-12-31 FY2021 | — | $-0.55 | — | |
2020-12-31 FY2020 | — | $0.00 | — | |
2020-05-31 FY2020 | — | $-1.00 | — | |
2018-05-31 FY2018 | — | $-1.52 | — | |
2017-05-31 FY2017 | — | $-0.06 | — | |
2016-05-31 FY2016 | — | $-1.59 | — | |
2015-05-31 FY2015 | — | $-1.93 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Mosaic ImmunoEngineering Inc. (CPMV) measures how much investors pay for each dollar of the company's trailing earnings. CPMV's current PE ratio of N/A is calculated by dividing its stock price of $0.69 by its TTM earnings per share of -$0.09.
Frequently asked questions
CPMV pe ratio · 6 questionsCPMV's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.69 and TTM EPS of -$0.09. Data sourced from Financial Modeling Prep via CPMV's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Mosaic ImmunoEngineering Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09